Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    TKM-080301
Show Display Options
Rank Status Study
1 Recruiting A Study to Determine Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM 080301 in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients
Conditions: Cancer;   Neuroendocrine Tumors;   NET;   Adrenocortical Carcinoma;   ACC
Intervention: Drug: TKM-080301
2 Completed TKM 080301 for Primary or Secondary Liver Cancer
Conditions: Colorectal Cancer With Hepatic Metastases;   Pancreas Cancer With Hepatic Metastase;   Gastric Cancer With Hepatic Metastase;   Breast Cancer With Hepatic Metastase;   Ovarian Cancer With Hepatic Metastase
Intervention: Drug: TKM-080301
3 Recruiting Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Hepatoma;   Liver Cancer, Adult;   Liver Cell Carcinoma, Adult
Intervention: Drug: TKM-080301

Indicates status has not been verified in more than two years